核医学的新视角：拓展前列腺特异性膜抗原（PSMA）靶向成像与治疗的适应症 - Suppr

A new perspective for nuclear medicine: expanding the indications for PSMA targeted imaging and therapy.

作者信息

Verburg Frederik A, Luster Markus

机构信息

Department of Nuclear Medicine, University Hospital Marburg, Baldinger Strasse, 35043, Marburg, Germany.

出版信息

Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1611-1613. doi: 10.1007/s00259-017-3767-4. Epub 2017 Jul 4.

DOI:10.1007/s00259-017-3767-4

PMID:28677048

Abstract

摘要

相似文献

A new perspective for nuclear medicine: expanding the indications for PSMA targeted imaging and therapy.

Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1611-1613. doi: 10.1007/s00259-017-3767-4. Epub 2017 Jul 4.

PSMA-Targeted Radiopharmaceuticals for Imaging and Therapy.

Semin Nucl Med. 2019 Jul;49(4):302-312. doi: 10.1053/j.semnuclmed.2019.02.008. Epub 2019 Apr 30.

[¹⁷⁷Lu]Lutetium-labelled PSMA ligand-induced remission in a patient with metastatic prostate cancer.

Eur J Nucl Med Mol Imaging. 2015 May;42(6):987-8. doi: 10.1007/s00259-014-2978-1. Epub 2015 Jan 9.

Meeting report from the Prostate Cancer Foundation PSMA-directed radionuclide scientific working group.

Prostate. 2018 Aug;78(11):775-789. doi: 10.1002/pros.23642. Epub 2018 May 1.

PSMA-Targeting Imaging and Theranostic Agents-Current Status and Future Perspective.

Int J Mol Sci. 2022 Jan 21;23(3):1158. doi: 10.3390/ijms23031158.

The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer.

J Nucl Med. 2016 Oct;57(Suppl 3):79S-89S. doi: 10.2967/jnumed.115.170720.

Current Status of Prostate-Specific Membrane Antigen Targeting in Nuclear Medicine: Clinical Translation of Chelator Containing Prostate-Specific Membrane Antigen Ligands Into Diagnostics and Therapy for Prostate Cancer.

Semin Nucl Med. 2016 Sep;46(5):405-18. doi: 10.1053/j.semnuclmed.2016.04.004.

Prostate-Specific Membrane Antigen Biology and Pathophysiology in Prostate Carcinoma, an Update: Potential Implications for Targeted Imaging and Therapy.

Int J Mol Sci. 2024 Sep 9;25(17):9755. doi: 10.3390/ijms25179755.

Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer: An Update on Important Pitfalls.

Semin Nucl Med. 2019 Jul;49(4):255-270. doi: 10.1053/j.semnuclmed.2019.02.006. Epub 2019 Mar 4.

PSMA Expression Assessed by PET Imaging Is a Required Biomarker for Selecting Patients for Any PSMA-Targeted Therapy.

J Nucl Med. 2021 Nov;62(11):1489-1491. doi: 10.2967/jnumed.121.263159.

引用本文的文献

Prostate-Specific Membrane Antigen in Anaplastic and Poorly Differentiated Thyroid Cancer-A New Diagnostic and Therapeutic Target?

Cancers (Basel). 2021 Nov 14;13(22):5688. doi: 10.3390/cancers13225688.

Recent advances in theranostics and challenges for the future.

Br J Radiol. 2018 Nov;91(1091):20170893. doi: 10.1259/bjr.20170893. Epub 2018 Mar 29.

本文引用的文献

Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis.

Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1614-1621. doi: 10.1007/s00259-017-3737-x. Epub 2017 Jun 7.

Comparison of PSMA-HBED and PSMA-I&T as diagnostic agents in prostate carcinoma.

Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1455-1462. doi: 10.1007/s00259-017-3699-z. Epub 2017 May 4.

Incidental Detection of Thyroid Metastases From Renal Cell Carcinoma Using 68Ga-PSMA PET/CT to Assess Prostate Cancer Recurrence.

Clin Nucl Med. 2017 Mar;42(3):221-222. doi: 10.1097/RLU.0000000000001522.

PSMA Expression in Tumor Neovasculature Endothelial Cells of Follicular Thyroid Adenoma as Identified by Molecular Imaging Using 68Ga-PSMA Ligand PET/CT.

Clin Nucl Med. 2017 Mar;42(3):e173-e174. doi: 10.1097/RLU.0000000000001487.

Unusual Uptake of Prostate Specific Tracer Ga-PSMA-HBED-CC in a Benign Thyroid Nodule.

Nucl Med Mol Imaging. 2016 Dec;50(4):344-347. doi: 10.1007/s13139-016-0408-y. Epub 2016 Mar 22.

Imaging of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-HBED-CC-PSMA PET/CT.

Clin Nucl Med. 2017 Jan;42(1):20-25. doi: 10.1097/RLU.0000000000001454.

Imaging: PSMA PET-CT in initial prostate cancer staging.

Nat Rev Urol. 2016 Sep;13(9):498-9. doi: 10.1038/nrurol.2016.136. Epub 2016 Jul 19.

225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer.

J Nucl Med. 2016 Dec;57(12):1941-1944. doi: 10.2967/jnumed.116.178673. Epub 2016 Jul 7.

Molecular imaging using PSMA PET/CT versus multiparametric MRI for initial staging of prostate cancer: comparing apples with oranges?

Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1397-9. doi: 10.1007/s00259-016-3389-2. Epub 2016 Apr 27.

Detection of recurrent prostate cancer lesions before salvage lymphadenectomy is more accurate with (68)Ga-PSMA-HBED-CC than with (18)F-Fluoroethylcholine PET/CT.

Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1410-7. doi: 10.1007/s00259-016-3366-9. Epub 2016 Mar 19.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

A new perspective for nuclear medicine: expanding the indications for PSMA targeted imaging and therapy.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献